Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux...
Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience
About this item
Full title
Author / Creator
Publisher
India: Medknow Publications and Media Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
India: Medknow Publications and Media Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
Several series of patient studies have been published on the use of rFVIIa in traumatic haemorrhagic shock, although to date no international recommendations have been produced. France does not currently recognise traumatic haemorrhagic shock as an appropriate indication for the use of rFVIIa.
In this retrospective study, we present our experien...
Alternative Titles
Full title
Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_da5ab238f5514b478935f37dca639dfc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_da5ab238f5514b478935f37dca639dfc
Other Identifiers
ISSN
0974-2700
E-ISSN
0974-519X
DOI
10.4103/0974-2700.96483
